MDA-MB-231 and MCF-7 human breast cancer cell lines Raw sequence reads
We used RNA-seq technology to examine the gene expression differences between ER-positive breast cancer MCF-7 cells and triple-negative breast cancer MDA-MB-231 cells after treatment with Chidamida in order to clarify the specific mechanism of Chidamida 's anti-breast cancer effect and to lay the groundwork for the treatment of malignant tumors, particularly difficult-to-treat advanced breast cancer, and the development of new drugs.